Pediatric Lyme Disease Clinical Presentation
- Author: Russell W Steele, MD; Chief Editor: Russell W Steele, MD more...
History
Most patients with Lyme disease do not recall a tick bite. The clinical presentation depends on the stage at which the disease is recognized: (1) early disease, (2) early disseminated disease, or (3) late disease.
Early disease
Early disease usually develops 7-14 days after a tick bite. Two thirds of patients with Lyme disease present with the typical rash, erythema migrans (EM).[2] The rash may be a confluent patch of erythema or may have central clearing. The rash typically expands over days and is not evanescent. EM is a clinical diagnosis, and serologic testing for children with a single EM lesion is generally not recommended because patients may be seronegative early in the course of illness.
During early disease, with or without the rash, patients may complain of a flulike illness characterized by fever, chills, myalgias, arthralgias, headache, and malaise. In the area of the tick bite, tender adenopathy may be noted.
Early disseminated disease
Early disseminated disease usually develops 3-10 weeks after inoculation. Approximately 25% of individuals infected with B burgdorferi have signs and symptoms of disseminated disease at presentation.
Multiple EM lesions are present. These are relatively small erythematous macules (1-5 cm) and are often oval. Unlike primary single EMs, these lesions can be evanescent and do not show the typical expansion over days.
Patients with early disseminated disease may complain of fever, myalgias, arthralgias, malaise, and headache. Persistent headache alone is a rare presentation of Lyme disease but should be considered in patients in endemic areas during summertime.
Cranioneuropathies, especially peripheral seventh nerve palsy (Bell palsy), are common (3% of Lyme disease). In endemic areas, Lyme disease is the most commonly identified cause of acquired facial palsy, especially in children[3] Headache, absence of previous herpetic lesions, and meningeal symptoms are noted in most pediatric Lyme disease patients with facial palsy.
Aseptic meningitis may develop at this stage. Encephalitis is rare. Carditis may present as complete heart block.
Late disease
Late disease develops weeks to months after inoculation. Its hallmark is arthritis, which tends to involve large joints (the knee is involved in 90% of cases). Arthritis must be differentiated from arthralgia, which is common in early disease.
Most patients presenting with late disease do not have a history of EM, because the rash typically leads to earlier treatment, which prevents the development of late disease.
Physical Examination
Early disease
Physical findings in patients with early disease are as follows:
- EM rash - Confluent or central clearing, expands over days, not evanescent, more common on head or neck in young children and on extremities in older children, characteristic large (>2 cm) macules, which are round or oval and may be more difficult to recognize on the face, neck, or axilla
- Fever
- Myalgias
- Malaise
- Arthralgia
- Patient appears in discomfort due to headache or myalgias
- Tender adenopathy (local, not diffuse)
Early disseminated disease
Physical findings in patients with early disseminated disease are as follows:
- Multiple EM lesions: Twenty-five percent of patients with Lyme disease present with multiple EM. Eighty-nine percent of patients with disseminated Lyme disease present with at least one EM lesion.
- Headache
- Fever
- Tender adenopathy (regional or generalized)
- Conjunctivitis (uncommon, never prominent)
- Carditis (usually manifests as heart block)
- Meningismus as a sign of aseptic meningitis
- Cranioneuropathy, especially cranial nerve VII and Bell palsy (peripheral seventh nerve palsy with decreased unilateral function, including the forehead)
Late disease
In patients with late disease, the typical physical finding is arthritis. Arthritis is located mostly in large joints, especially the knee. Warmth, swelling from effusion, and limited range of motion help distinguish arthritis from simple arthralgia.
Complications
The agents responsible for babesiosis and ehrlichiosis share the same tick vector as B burgdorferi, making co-infection possible. Severe and even fatal acute infection caused by these agents is more common in asplenic individuals (babesiosis) or older adults (Ehrlichia); however, unlike B burgdorferi, chronic infection by these agents is not observed. To add to the confusion, ehrlichial infection may cause a false-positive result for Lyme disease on immunoglobulin M (IgM) Western blot analysis.
One nonmedical complication of Lyme disease has been the public and media’s misconceptions about the disease. Unfortunately, many clinicians perform too many tests when the prior probability of disease is low, resulting in many false-positive tests.
The combination of nonspecific symptoms and suboptimal test results has led to overtreatment for suspected (but not proven) Lyme disease and to the concept of refractory Lyme disease.
Go to Ophthalmic Aspects of Lyme Disease for complete information on this topic.
Feder HM Jr. Lyme disease in children. Infect Dis Clin North Am. Jun 2008;22(2):315-26, vii. [Medline].
Halperin JJ. Nervous system lyme disease: diagnosis and treatment. Rev Neurol Dis. Winter 2009;6(1):4-12. [Medline].
Nigrovic LE, Thompson AD, Fine AM, Kimia A. Clinical predictors of Lyme disease among children with a peripheral facial palsy at an emergency department in a Lyme disease-endemic area. Pediatrics. Nov 2008;122(5):e1080-5. [Medline].
Cohn KA, Thompson AD, Shah SS, Hines EM, Lyons TW, Welsh EJ, et al. Validation of a clinical prediction rule to distinguish lyme meningitis from aseptic meningitis. Pediatrics. Jan 2012;129(1):e46-53. [Medline].
Burbelo PD, Issa AT, Ching KH, Cohen JI, Iadarola MJ, Marques A. Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease. Clin Vaccine Immunol. Jun 2010;17(6):904-9. [Medline]. [Full Text].
Li X, McHugh GA, Damle N, Sikand VK, Glickstein L, Steere AC. Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis. Arthritis Rheum. Aug 2011;63(8):2238-47. [Medline].
[Guideline] Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. Jul 3 2007;69(1):91-102. [Medline].
[Guideline] The ILADS Working Group. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti Infect Ther. 2004;2(1 Suppl):S1-13.
[Guideline] Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. Nov 1 2006;43(9):1089-134. [Medline].
Warshafsky S, Lee DH, Francois LK, Nowakowski J, Nadelman RB, Wormser GP. Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis. J Antimicrob Chemother. Jun 2010;65(6):1137-44. [Medline].

